Patients with high DCBLD2 expression had a shorter survival time and a poor prognosis in the TCGA colon cancer patients receiving 5-FU treatment and the GSE17536 data set (Figures 1D,E). The gene discussed is DCBLD2; the disease is malignant colon neoplasm.